Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

Morning Watch: ONGC Scales Up Energy Footprint, Biocon's New Drug Approved & More

Published 03/12/2021, 02:56
Updated 03/12/2021, 02:56
© Reuters.

© Reuters.

By Malvika Gurung

Investing.com -- The Nifty 50 Futures listed on the Singapore-based Exchange SGX, an early indicator for Nifty50, was found trading marginally lower by 0.4% at 17,380 at 7:55 am on Friday, indicating the Dalal Street to open make a negative to muted start today, tracking weakness across some Asian markets, despite a broad rally across the Wall Street overnight. At the same time, the Dow Jones Futures was trading 0.31% lower.

Biocon (NS:BION): Biocon Pharma, a subsidiary of the biotech major received the approval for its abbreviated new drug application for Mycophenolic Acid from the US health regulator, USFDA.

Tata Power Co. Ltd (NS:TTPW): The electric power distribution company’s shareholders have approved the revision of a series of arrangements to keep its subsidiary Tata Power Solar Systems Ltd as an independent entity.

ONGC (NS:ONGC): The state-owned major entered into an agreement with the Solar Energy Corporation of India on Thursday, to scale up its clean energy projects, in a bid to grab a stronger hold in the renewable space.

Bharat Dynamics Ltd (NS:BARA): The defence ammunition manufacturer and the Indian Army have signed a contract worth Rs 471.41 crore for refurbishing IGLA - 1M missiles, which will last for 10 years, informed the defence PSU in a regulatory filing.

Cement Stocks: According to the domestic rating agency Crisil, the retail prices of cement is expected to rise further by Rs 15-20 in the upcoming few months and could touch an all-time high of nearly Rs 400/bag, due to the increasing cost pressure of inputs commodities, like coal and diesel.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.